SIG
IDXX icon

Sargent Investment Group’s Idexx Laboratories IDXX Stock Holding History

Sargent Investment Group’s Portfolio IDXX Stock Details IDXX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$745K Hold
1,325
– – 0.1% 127
2025
Q4 		$896K Buy
+1,325
New +$902K 0.11% 122
2025
Q3 		– Sell
-1,424
Closed -$889K – 171
2025
Q2 		$889K Buy
1,424
+1
+0.1% +$478 0.12% 110
2025
Q1 		$598K Buy
+1,423
New +$618K 0.1% 130

Other funds holding IDXX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $33.1B AUM 11.16% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Fundsmith LLP
Fundsmith LLP London, United Kingdom $12.8B AUM 6.9% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Sargent Investment Group's IDXX Position: Q1 2026 in Review

Sargent Investment Group held its Idexx Laboratories (IDXX) position steady in Q1 2026 at 1,325 shares worth $745K. The position accounts for 0.1% of the portfolio, ranked #127.

Sargent Investment Group first reported a position in IDXX in Q1 2025 and has held it in 4 quarters since. The position peaked at $896K in Q4 2025. 1,312 funds tracked by Wall St. Rank hold IDXX as of Q1 2026.

  • Sargent Investment Group held 1,325 shares of Idexx Laboratories worth $745K as of Q1 2026.
  • Sargent Investment Group left its Idexx Laboratories share count unchanged in Q1 2026.
  • Idexx Laboratories made up 0.1% of Sargent Investment Group's portfolio in Q1 2026, its #127 holding.
  • Sargent Investment Group first reported a position in Idexx Laboratories in Q1 2025 and has held it in 4 quarters since.
  • Sargent Investment Group's Idexx Laboratories position peaked at $896K in Q4 2025.
  • 1,312 funds tracked by Wall St. Rank held Idexx Laboratories as of Q1 2026.

Based on Sargent Investment Group's 13F filing for Q1 2026, filed 11 May 2026.